Status:
ACTIVE_NOT_RECRUITING
Lung Transplant READY CF 2: A Multi-site RCT
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Institute of Nursing Research (NINR)
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Lung transplant is an option for treating end-stage lung disease in cystic fibrosis (CF). In the United States, more people with CF and low lung function die each year than undergo lung transplant. Mo...
Detailed Description
Lung transplant is an option for treating end-stage lung disease in cystic fibrosis (CF). In the United States, more people with CF with forced expiratory volume in 1 second (FEV1) less than 30% of pr...
Eligibility Criteria
Inclusion
- Diagnosis of cystic fibrosis
- FEV1 less than 50% of predicted
Exclusion
- People who are unable to provide informed consent
- People who are lung transplant recipients
- Unable to read or understand English or Spanish to complete surveys or access the website (currently only available in English and Spanish)
Key Trial Info
Start Date :
September 6 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2027
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT06030206
Start Date
September 6 2023
End Date
May 31 2027
Last Update
January 5 2026
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California at Los Angeles (UCLA)
Los Angeles, California, United States, 980095
2
National Jewish Health
Denver, Colorado, United States, 80206
3
Yale University
New Haven, Connecticut, United States, 06520
4
University of Kansas
Kansas City, Kansas, United States, 66160